An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition: HypertensionInterventions: Drug: Aliskiren; Drug: EnalaprilSponsors: Novartis; Novartis PharmaceuticalsRecruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials
An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition: HypertensionInterventions: Drug: Aliskiren; Drug: EnalaprilSponsors: Novartis; Novartis PharmaceuticalsRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials
An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition: HypertensionInterventions: Drug: Aliskiren; Drug: EnalaprilSponsors: Novartis; Novartis PharmaceuticalsRecruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials
An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition: HypertensionInterventions: Drug: Aliskiren; Drug: EnalaprilSponsors: Novartis; Novartis PharmaceuticalsRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials
An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition: HypertensionInterventions: Drug: Aliskiren; Drug: EnalaprilSponsors: Novartis; Novartis PharmaceuticalsRecruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2010 Category: Research Source Type: clinical trials
The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes
Condition: Diabetes Type 2Interventions: Drug: Placebo; Drug: AliskirenSponsors: Beth Israel Deaconess Medical Center; Novartis PharmaceuticalsCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2009 Category: Research Source Type: clinical trials
Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
Conditions: Microalbuminuria; Macroalbuminuric Diabetic Nephropathy; Diabetes; Proteinuria; AlbuminuriaInterventions: Drug: Aliskiren; Drug: AliskirenSponsor: John H. Stroger HospitalTerminated - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2009 Category: Research Source Type: clinical trials